Columbus Venture Partners
14
35M
11
3
0.14
1
- Areas of investment
Summary
We can highlight the next thriving fund investment areas, such as Biopharma, Biotechnology. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Aura Biosciences, SANIFIT, Vivet Therapeutics. Besides, a startup needs to be aged 11-15 years to get the investment from the fund.
The important activity for fund was in 2017. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Columbus Venture Partners, startups are often financed by Ysios Capital, Caixa Capital Risc, la Caixa. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Lundbeckfonden Ventures, Roche Venture Fund. In the next rounds fund is usually obtained by Pfizer, Medicxi Ventures.
We also calculated 2 valuable employees in our database.
Investments analytics
Analytics
- Total investments
- 14
- Lead investments
- 3
- Exits
- 1
- Follow on index
- 0.14
- Investments by industry
- Biotechnology (12)
- Health Care (6)
- Medical (4)
- Biopharma (4)
- Pharmaceutical (3) Show 7 more
- Investments by region
-
- Spain (7)
- United States (4)
- United Kingdom (2)
- France (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 34M
- Group Appearance index
- 0.86
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Multiverse Computing | 05 Mar 2024 | Software | Early Stage Venture | 29M | Autonomous Community of the Basque Country, San Sebastián, Spain |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.